Difference between revisions of "BEECH(F23):Build Knowledge"
Becky Meyer (Talk | contribs) (→Gene editing) |
Becky Meyer (Talk | contribs) (→Development of diagnostic and laboratory tools) |
||
| Line 28: | Line 28: | ||
[https://news.mit.edu/2021/glioblastoma-cancer-cell-mass-1005 Using cell mass as a new cancer diagnostic] <br> | [https://news.mit.edu/2021/glioblastoma-cancer-cell-mass-1005 Using cell mass as a new cancer diagnostic] <br> | ||
[https://news.mit.edu/2021/counting-cells-cancer-0928 Counting circulating tumor cells as a marker of cancer progression]<br> | [https://news.mit.edu/2021/counting-cells-cancer-0928 Counting circulating tumor cells as a marker of cancer progression]<br> | ||
| + | [https://news.mit.edu/2021/pancreatic-organoids-cancer-0913 Growing pancreatic organoids] <br> | ||
===Drug delivery=== | ===Drug delivery=== | ||
Revision as of 20:12, 15 November 2023
Overview
Notes about how to use this page
Press releases about current MIT biotechnology research
Agriculture and Climate science
Sustainable palm oil alternative
Biomaterials
DNA-scaffold quantum rods
Light-responsive muscle grafts
Computational biology
Computational screening for drug discovery
AI model for biology research
Computational model for effective DNA editing
Disease biology
Influence of cell fate on cancer progression
Previously unknown immune response regulator
Modulating immune cells for cancer therapy
Development of diagnostic and laboratory tools
Mapping a 3D genome
Using cell mass as a new cancer diagnostic
Counting circulating tumor cells as a marker of cancer progression
Growing pancreatic organoids
Drug delivery
Bacteriophage delivery system
Nanoparticle drug delivery
Vaccine boost for CAR-T cell cancer therapy
Gene editing
Targeting RNA therapies
Programmable RNA to edit genome
Programmable enzymes for gene editing
Microbes
Bacteria communication and antibiotic resistance
